1. Doxorubicin-induced upregulation of follistatin-like 3 (FSTL3): a new therapeutic target. (3rd October 2022) Authors: Chen, D; Croft, A; Kelly, C; Haw, T J; Leong, A; Sverdlov, A; Ngo, D Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Follistatin-like 3 (FSTL3) levels are increased in acute heart failure patients. (14th October 2021) Authors: Chen, D; Untaru, R; Liu, S; Assadi-Khansari, B; Croft, A; Kelly, C; Ajaero, C; Chua, S J; Boyle, A J; Horowitz, J D; Ngo, D; Sverdlov, A Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗